Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Christina A. Meyers, PhD

M.D. Anderson Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Cognitive/Functional EffectsMetastatic CancerNeurotoxicity+1 more

Worked with same sponsors:

National Cancer Institute (NCI)NRG Oncology+1 more
Collaborated on 1 trial
Similarity Score44%

Sherry Fox, RN, PhD

Bon Secours Cancer Institute at St. Mary's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Cognitive/Functional EffectsMetastatic CancerNeurotoxicity+1 more

Worked with same sponsors:

National Cancer Institute (NCI)NRG Oncology+1 more
Collaborated on 1 trial
Similarity Score44%

Paul D. Brown, MD

Mayo Clinic

Moderately Similar
3 trials

Shared therapeutic areas:

Cognitive/Functional EffectsMetastatic CancerNeurotoxicity+1 more

Worked with same sponsors:

National Cancer Institute (NCI)NRG Oncology+1 more
Collaborated on 1 trial
Similarity Score44%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificCognitive/Functional EffectsMetastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Edward G. Shaw, MD

Wake Forest University Health Sciences

Related
12 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificCognitive/Functional EffectsMetastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)NRG Oncology+1 more
Similarity Score23%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificMetastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Charles L. Loprinzi, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificNeurotoxicity

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)Radiation Therapy Oncology Group
Similarity Score15%

Primo N. Lara, MD

University of California, Davis

Related
13 trials

Shared therapeutic areas:

Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)NRG Oncology+1 more
Similarity Score15%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00566852Phase 3StudyChair

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Cognitive/Functional EffectsMetastatic CancerNeurotoxicity+1 more
Completed

All 1 trials loaded